Advanced search    

Search: authors:"Jason Bacharach"

3 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum] Tauber J, Schechter BA, Bacharach J, et al. Clin Ophthalmol. 2018;12:1921–1929. On page 1924, Efficacy end points, Conjunctival staining section, the sentence “Statistically significant reductions in the mean...

Repeatability of selective laser trabeculoplasty for open-angle glaucoma

Kinast 5 Jason Bacharach 4 Sunita Radhakrishnan 4 Andrew Iwach 4 Lidiya Rudavska 9 Parul Ichhpujani 8 L. Jay Katz 8 0 Equal contributors 1 Department of Ophthalmology, David Geffen School of Medicine at

A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy

William A. Argus, MD, Fort Wayne, IN; Jason Bacharach, MD, Petaluma, CA; Richard Chace, MD, Portsmouth, NH; Douglas Day, MD, Roswell, GA; Deepak P. Edward, MD, Akron, OH; Andrew Iwach, MD, San Francisco, CA